Cd3eap (CD3e molecule-associated protein), also termed RPA34 or PAF49, is a subunit of RNA polymerase I (Pol I) responsible for transcribing rRNA genes. Key attributes include:
Recombinant mouse Cd3eap is typically expressed in Escherichia coli for research applications. Commercial variants include:
Transcription Elongation: Cd3eap/RPA34 forms a heterodimer with RPA49 (PAF53 in humans) to enhance Pol I processivity. Deletion results in reduced rRNA production and defective ribosome biogenesis .
Nucleolar Structure:
Functional complementation assays demonstrate cross-species compatibility:
Polyclonal antibodies (e.g., Boster Bio A30649) recognize recombinant Cd3eap in WB (1:500–1:2000 dilution), IHC (1:100–1:300), and ELISA (1:40,000) .
Epitope mapping confirms reactivity to residues 441–490 of human CD3EAP, with cross-reactivity in mouse and rat .
Cancer: Cd3eap overexpression correlates with elevated rRNA synthesis in proliferating cells, a hallmark of malignancies .
Immunology: Isoform 2 participates in preformed T-cell receptor (TCR) complexes, hinting at non-canonical roles in immune signaling .
Nucleolar Assembly: RPA34/RPA49 deletion in yeast collapses nucleolar structure, reversible only by reducing rRNA gene copy number .
Drug Sensitivity: Cd3eap-deficient cells exhibit hypersensitivity to mycophenolate and 6-azauracil, linking Pol I integrity to nucleotide metabolism .
Structural Analysis: Cryo-EM studies suggest RPA34 stabilizes Pol I–rDNA interactions during elongation .